A examine revealed in JAMA Community Open emphasizes the discrepancy among what it prices to generate copyright and also the retail prices people confront. Despite the low production charges, Novo Nordisk has not publicly disclosed certain figures for copyright or its other products, Wegovy.This led Novo Nordisk to conduct additional investigation